According to the research report titled ‘Urinalysis Market Size By Product (Consumables {Dipsticks, Reagents, Disposables}, Instruments {Biochemical Urine Analyzer, Automated Urine Sediment Analyzer}), By Application (Urinary Tract Infections, Kidney Diseases, Pregnancy, Diabetes), By End-use (Clinical Laboratories, Hospitals, Home Healthcare), COVID-19 Impact Analysis, Regional Outlook, Growth Potential, Price Trends, Competitive Market Share & Forecast, 2021 – 2027’, available with MarketStudyReport, global urinalysis market is anticipated to witness robust growth through 2027.

Report findings suggest that growing geriatric population, and rising incidences of urinary tract infections (UTI) are primarily driving the growth of global urinalysis market.

Request sample copy of this report: https://www.marketstudyreport.com/request-a-sample/4547858/

For the unversed, urinalysis, also known as a urine test, is the analysis of a patient's urine sample to diagnose diseases and infections such as urinary tract infections (UTI), kidney diseases, diabetes, liver diseases, and pregnancy tests. The examination is divided into three parts: a visual examination, a microscopic examination, and a dipstick test.

High global pregnancy rate has increased demand for precise tests, which along with growing advancements in diagnostic procedures, and an increase in the number of infections globally have augmented the industry outlook in the recent years.

In terms of product gamut, the consumables segment is anticipated to showcase substantial growth with a CAGR of 5.4% through 2027, on account of escalating demand for dipsticks & reagents for quick testing.

Based on application ambit of worldwide urinalysis market, the kidney diseases segment had a valuation of USD 696 million in 2020 and is expected to expand rapidly during the forecast period, owing to rising prevalence of kidney diseases among the world's geriatric population.

On the basis of end-use spectrum, the clinical laboratories segment is poised to grow at a CAGR of 5.7% over the forecast timeline, because of the availability of advanced and specialised urine analysers in these settings.

Regionally, Latin America industry exceeded a valuation of USD 256.2 million in 2020 and is anticipated to garner lucrative returns over the analysis timeframe.

The key players in worldwide urinalysis marketplace are Teco Diagnostics, Hycel Medical, Arkray USA Inc., Bio-Rad Laboratories Inc., Abbott Laboratories, Cardinal Health Inc., Acon Laboratories Inc., ERBA Diagnostics Inc, F. Hoffmann-La Roche AG, and Sysmex Corporation.